Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)
Saudi Arabia · Delayed Price · Currency is SAR 30.36
-0.10 (-0.33%)
Nov 5, 2026, 3:13 PM AST
TADAWUL:4017 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,983 | 7,843 | 15,410 | - | - | - | |
Market Cap Growth | -25.04% | -49.10% | - | - | - | - |
Enterprise Value | 8,408 | 8,916 | 16,085 | - | - | - |
Last Close Price | 30.36 | 33.80 | 65.92 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 30.07 | 27.03 | 53.59 | - | - | - |
Forward PE | 20.52 | 22.08 | 42.58 | - | - | - |
PS Ratio | 2.25 | 2.54 | 5.52 | - | - | - |
PB Ratio | 1.94 | 2.19 | 4.64 | - | - | - |
P/TBV Ratio | 2.64 | 2.99 | 6.42 | - | - | - |
P/OCF Ratio | 14.24 | 17.28 | 35.34 | - | - | - |
PEG Ratio | 0.83 | 1.49 | 2.08 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.71 | 2.89 | 5.76 | - | - | - |
EV/EBITDA Ratio | 18.41 | 21.05 | 34.93 | - | - | - |
EV/EBIT Ratio | 31.88 | 28.95 | 44.80 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.38 | 0.33 | 0.33 | 1.80 | 1.04 | 0.69 |
Debt / EBITDA Ratio | 3.00 | 2.42 | 2.08 | 4.72 | 4.58 | 2.50 |
Debt / FCF Ratio | 7.12 | - | - | 70.07 | - | 6.84 |
Net Debt / Equity Ratio | 0.28 | 0.21 | 0.16 | 1.63 | 0.90 | 0.58 |
Net Debt / EBITDA Ratio | 2.60 | 1.74 | 1.18 | 4.78 | 4.28 | 2.29 |
Net Debt / FCF Ratio | 5.27 | -97.08 | -6.67 | 63.44 | -13.98 | 5.74 |
Asset Turnover | 0.53 | 0.55 | 0.58 | 0.50 | 0.47 | 0.59 |
Inventory Turnover | 11.54 | 12.73 | 12.24 | 11.61 | 11.26 | 11.29 |
Quick Ratio | 1.20 | 1.33 | 1.69 | 1.04 | 0.94 | 1.78 |
Current Ratio | 1.50 | 1.63 | 1.97 | 1.30 | 1.19 | 2.25 |
Return on Equity (ROE) | 5.49% | 7.19% | 11.53% | 13.60% | 17.04% | 23.16% |
Return on Assets (ROA) | 2.82% | 3.45% | 4.70% | 4.49% | 5.60% | 7.07% |
Return on Invested Capital (ROIC) | 5.02% | 6.66% | 9.20% | 8.23% | 10.56% | 14.23% |
Return on Capital Employed (ROCE) | 5.50% | 6.50% | 8.20% | 10.50% | 9.80% | 12.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.33% | 3.70% | 1.87% | - | - | - |
FCF Yield | 2.76% | -0.10% | -0.53% | - | - | - |
Dividend Yield | 1.09% | 0.97% | 0.45% | - | - | - |
Payout Ratio | 29.72% | 23.78% | - | 411.31% | 10.73% | 6.76% |
Buyback Yield / Dilution | 0.01% | -5.90% | -8.59% | - | -100.00% | - |
Total Shareholder Return | 1.10% | -4.94% | -8.14% | - | -100.00% | - |